which glp 1 least side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists common side effects of GLP-1
Description
At this time, GLP-3 style medications such as retatrutide are still investigational and not FDA-approved for routine weight loss treatment
The early signs are easy to brush off
It happens quietly, without you realizing it
The Wegovy-vs-Zepbound gap is consistent with mechanism: Wegovy activates only the GLP-1 receptor at a high obesity-management dose, while tirzepatide adds GIP receptor activity that may modestly buffer some GI effects
Do not use a GLP-1 agonist if you have had a serious allergic reactions to Wegovy (semaglutide), Zepbound (tirzepatide) or Saxenda (liraglutide) or any of the ingredients in these medications
As such, unimolecular co-agonists have been the primary area of clinical relevance
